Texas Capital Bancshares Inc
$ 22.54
1.30%
04 Mar - close price
- Market Cap 3,313,076,000 USD
- Current Price $ 22.54
- High / Low $ 22.67 / 22.22
- Stock P/E 5.62
- Book Value 75.28
- EPS 3.96
- Next Earning Report 2026-04-15
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date 2026-03-16
- ROA 0.01 %
- ROE 0.09 %
- 52 Week High 22.30
- 52 Week Low 16.90
About
Texas Capital Bancshares Inc (TCBIO) is a leading financial services provider headquartered in Dallas, Texas, specializing in comprehensive banking solutions for commercial and private clients. The company offers a diverse range of products, including business loans, treasury management, and personal banking services, leveraging its regional expertise to build enduring customer relationships. As a publicly traded institution, TCBIO emphasizes disciplined risk management and strategic expansion, strategically positioning itself in the competitive banking landscape. With a strong capital foundation and a customer-focused approach, Texas Capital Bancshares is poised to seize emerging market opportunities and drive sustainable growth for its shareholders.
Analyst Target Price
N/A
Quarterly Earnings
| Dec 2025 | Sep 2025 | |
|---|---|---|
| Reported Date | 2026-01-21 | 2025-10-23 |
| Reported EPS | 2.12 | 2.18 |
| Estimated EPS | None | 0 |
| Surprise | 0 | 2.18 |
| Surprise Percentage | None% | None% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-15 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-16 | 2025-12-15 | 2025-09-15 | 2025-06-16 | 2025-03-17 | 2024-12-16 | 2024-09-16 | 2024-06-17 | 2024-03-15 | 2023-12-15 |
| Amount | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 | $0.359375 |
Next Dividend Records
| Dividend per share (year): | N/A |
| Dividend Yield | 0% |
| Next Dividend Date | 2026-03-16 |
| Ex-Dividend Date | 2026-03-02 |
Recent News: TCBIO
2026-03-02 07:35:04
Robert W. Stallings, a director at Texas Capital Bancshares, recently purchased 40,000 depositary shares for approximately $888,000. These shares, known as TCBIO, represent ownership interests in Series B Preferred shares and offer dividends but no voting power, unlike the common stock TCBI. The transaction occurred amidst a positive stock performance for the company in 2026, though its financials have seen recent fluctuations and operational focus is limited to Texas.
2026-02-27 21:53:19
Texas Capital Bancshares (TCBI) has successfully completed a $400 million public offering of 5.301% fixed-to-floating rate senior notes due 2032. The proceeds from this offering will be utilized for general corporate purposes, including the potential redemption of its 4.000% subordinated notes due 2031, thereby strengthening the company's funding profile and capital flexibility. An AI analyst has rated TCBI as "Outperform," citing improved financial performance, a constructive earnings outlook, and supportive technicals.
2026-02-27 20:53:19
Texas Capital Bancshares recently completed an offering of $400 million in 5.301% Fixed-to-Floating Rate Senior Notes due 2032, generating $398.4 million in proceeds. The interest will be fixed until February 27, 2031, then switch to a floating rate based on compounded SOFR plus 1.94%. The net proceeds are intended for general corporate purposes, including the potential redemption of existing subordinated notes.
2026-02-27 15:53:19
This article provides a technical analysis of Texas Capital Bancshares Inc. Depositary Shares (TCBIO), highlighting neutral near-term readings and potentially stalling mid-term strong sentiment. It identifies institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The analysis, generated by AI models, aims to offer insights into TCBIO's price positioning and risk parameters.
2026-02-27 12:53:19
Vanguard Group Inc. reduced its stake in Texas Capital Bancshares, Inc. ($TCBI) by 1.6% in the third quarter, selling 74,604 shares. Despite this, the company saw significant insider buying from directors Robert W. Stallings and Laura L. Whitley. Texas Capital Bancshares reported strong Q3 earnings, beating analyst estimates, although the consensus rating from analysts remains "Hold" with an average price target near its current trading price.
2026-02-27 10:53:19
Intech Investment Management LLC significantly increased its stake in Texas Capital Bancshares (NASDAQ:TCBI) by 355.1% in Q3, purchasing 107,356 shares to hold a total of 137,587 shares valued at approximately $11.63 million. Institutional investors now own about 96.88% of the company, while corporate insiders also recently bought shares, boosting their ownership to 1.72%. Texas Capital Bancshares exceeded Q4 earnings expectations with an EPS of $2.08 against an estimated $1.78, and currently holds a "Hold" consensus rating from analysts with an average target price of $101.17.
